Embolization device constructed from expansile polymer

Patent metadata

Field	Value
Publication number	US-9259228-B2
Application number	US-201313745258-A
Country	US
Kind code	B2
Filing date	Jan 18, 2013
Priority date	Jun 15, 2006
Publication date	Feb 16, 2016
Grant date	Feb 16, 2016

Abstract

Devices for the occlusion of body cavities, such as the embolization of vascular aneurysms and the like, and methods for making and using such devices. The devices may be comprised of novel expansile materials, novel infrastructure design, or both. The devices provided are very flexible and enable deployment with reduced or no damage to bodily tissues, conduits, cavities, etceteras.

First claim

We claim:

1. A method for preparing an expansile element formed of an environmentally-responsive hydrogel for implantation in an animal, the method comprising:
a) reacting a prepolymer solution including at least one ethylenically unsaturated macromer, at least one macromer or monomer comprising at least one pH sensitive ionizable functional group and an ethylenically unsaturated moiety, at least one polymerization initiator, and at least one solvent to prepare a hydrogel as the expansile element; and
b) treating said hydrogel to prepare an environmentally-responsive hydrogel that is responsive at physiological conditions,
wherein the expansile element has an unexpended bending resistance of from about 0.1 mg to about 50 mg.

2. A method according to claim 1 wherein said at least one ionizable functional group comprises an acidic group.

3. A method according to claim 2 wherein said treating comprises incubating said hydrogel in an acidic environment to protonate said acidic groups.

4. A method according to claim 2 wherein said acidic group comprises a carboxylic acid, a derivative thereof, or combinations thereof.

5. A method according to claim 1 wherein said at least one ionizable functional group comprises a basic group.

6. A method according to claim 5 wherein said treating comprises incubating said hydrogel in a basic environment to de-protonate said basic group.

7. A method according to claim 6 wherein said basic group comprise an amine, derivatives thereof, or combinations thereof.

8. A method according to claim 1 wherein said solvent comprises water, ethyl alcohol, or combinations thereof.

9. A method according to claim 8 wherein said solvent comprises water.

10. A method according to claim 1 wherein said at least one macromer or monomer comprising at least one ionizable functional group comprises a vinyl group, an acrylate, a methacrylate, an acrylamide, derivatives thereof, or combinations thereof.

11. A method according to claim 1 wherein said at least one ethylenically unsaturated macromer comprises poly(ethylene glycol), derivatives thereof, or combinations thereof.

12. A method according to claim 1 wherein said at least one ethylenically unsaturated macromer comprises poly(ethylene glycol) di-acrylamide, poly(ethylene glycol) di-acrylate, derivatives thereof, or combinations thereof.

13. A method according to claim 12 wherein said at least one ethylenically unsaturated macromer comprises poly(ethylene glycol) di-acrylamide.

14. A method according to claim 1 wherein said ethylenically unsaturated macromer is at a concentration of about 5% to about 40% by weight of the prepolymer solution.

15. A method according to claim 1 wherein said solvent is at a concentration of about 20% to about 80% by weight of the prepolymer solution.

16. A method according to claim 1 wherein said prepolymer solution further comprises adding at least one cross-linking agent comprising a compound with a plurality of ethylenically unsaturated moieties.

17. A method according to claim 1 wherein said polymerization initiator comprises a reduction-oxidation polymerization initiator.

18. A method according to claim 1 wherein said polymerization initiator comprises N,N,N′,N′-tetramethylethylenediamine, ammonium persulfate, azobisisobutyronitrile, benzoyl peroxides, 2,2′-azobis(2-methylpropionaminide) dihydrochloride, derivatives thereof, or combinations thereof.

19. A method according to claim 1 wherein said reacting further comprises adding a porosigen.

20. A method according to claim 3 wherein said acidic groups are capable of being de-protonated after implantation in an animal.

21. A method according to claim 5 wherein said basic groups are capable of being protonated after implantation in an animal.

22. A method according to claim 1 wherein said ethylenically unsaturated macromer comprises poly(ethylene glycol) di-acrylamide, said at least one macromer or monomer comprising at least one ionizable functional group comprises sodium acrylate, said at least one polymerization initiator comprises ammonium persulfate and N,N,N,′,N′ tetramethylethylenediamine, and said solvent comprises water.

23. A method according to claim 1 wherein said ethylenically unsaturated macromer has a molecular weight of about 400 grams/mole to about 35,000 grams/mole.

24. A method according to claim 1 wherein said environmentally-responsive hydrogel is substantially non-resorbable.

25. A method according to claim 1 wherein said environmentally-responsive hydrogel is substantially free of acrylamide.

26. A method according to claim 1 wherein said at least one ethylenically unsaturated macromer is non-ionic.

Assignees

• Microvention Inc

Inventors

• Cruise Gregory M
• Constant Michael J
• Tran Terrance

Classifications

• A61L31/048

  obtained by reactions only involving carbon-to-carbon unsaturated bonds (A61L31/041 takes precedence) · CPC title

• A61L31/145

  Hydrogels or hydrocolloids · CPC title

• A61B17/12113 Primary

  within an aneurysm · CPC title

• A61L31/14

  Materials characterised by their function or physical properties {, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials} · CPC title

• A61L2400/04

  Materials for stopping bleeding · CPC title